Cation-Independent Mannose 6-Phosphate Receptor Deficiency Enhances β-Cell Susceptibility to Palmitate

Aaron C Baldwin1, Aaron Naatz1, Richard N Bohnsack1

  • 1Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Insights

Beta cells defend against palmitate toxicity through lysosomal protein degradation. Impaired lysosomal function, specifically defects in the cation-independent mannose 6-phosphate receptor (CI-MPR), enhances cell damage from excess palmitate.

Area of Science:

  • Cell Biology
  • Metabolic Diseases
  • Endocrinology

Background:

  • Palmitate impairs insulin secretion and beta-cell viability.
  • Aberrant protein palmitoylation is a known mechanism of palmitate-induced beta-cell damage.

Purpose of the Study:

  • To investigate the role of lysosomal protein degradation in beta-cell defense against palmitate toxicity.
  • To elucidate the function of the cation-independent mannose 6-phosphate receptor (CI-MPR) in this protective mechanism.

Main Methods:

  • Utilized RINm5F (CI-MPR deficient) and INS832/13 (CI-MPR expressing) cell lines.
  • Reconstituted CI-MPR expression in RINm5F cells and reduced CI-MPR expression in INS832/13 cells.
  • Assessed endoplasmic reticulum (ER) stress, cell viability, and lysosomal acid hydrolase activity under glucolipotoxic conditions.

Main Results:

  • RINm5F cells, lacking CI-MPR, are highly sensitive to palmitate.
  • CI-MPR reconstitution in RINm5F cells attenuated ER stress and palmitate toxicity.
  • INS832/13 cells expressing CI-MPR are resistant; reduced CI-MPR expression increased palmitate sensitivity.
  • Inhibition of lysosomal function in islets exacerbated glucolipotoxicity, which was prevented by inhibiting protein palmitoylation.

Conclusions:

  • Lysosomal protein degradation, mediated by CI-MPR, is a critical defense mechanism for beta cells against palmitate.
  • Defects in lysosomal function increase beta-cell sensitivity to palmitate-induced damage.
  • Maintaining normal lysosomal function is crucial for protecting beta cells from lipotoxicity.

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.9K
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.3K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers01:25

Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers

β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but...
1.5K
Introduction to Test of Independence01:21

Introduction to Test of Independence

In statistics, the term independence means that one can directly obtain the probability of any event involving both variables by multiplying their individual probabilities. Tests of independence are chi-square tests involving the use of a contingency table of observed (data) values.
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
3.0K
Hypothesis Test for Test of Independence01:16

Hypothesis Test for Test of Independence

The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
8.3K